Sponsored Seminar
Luncheon Seminar
LS1
September 25 (Thu) 11:50-12:40 Room 3（Hotel Nikko Kanazawa 4F「Tsuru A」）
Treatment strategies for multiple myeloma
- Chair
-
- Hiroyuki Takamatsu
- （Department of Hematology/Professor, Faculty of Transdisciplinary Sciences for Innovation, Institute of Transdisciplinary Sciences for Innovation, Kanazawa University,）
- Speaker
-
- Hideto Tamura
- （Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center）
- Sponsor
- Janssen Pharmaceutical K.K.
LS2
September 25 (Thu) 11:50-12:40 Room 4（Hotel Nikko Kanazawa 4F「Tsuru B」）
A novel flow cytometry for analyzing the immunosuppressive tumor microenvironment
- Chair
-
- Osamu Takeuchi
- （Department of Medical Chemistry Graduate School of Medicine, Kyoto University）
- Speaker
-
- Hiroyoshi Nishikawa
- （Division of Cancer Immunology, Research Institute / EPOC, National Cancer Center Division of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine Department of Immunology, Nagoya University Graduate School of Medicine）
- Sponsor
- Nippon Becton Dickinson Company, Ltd.
LS3
September 25 (Thu) 11:50-12:40 Room 5（Hotel Nikko Kanazawa 4F「Tsuru C」）
Evolutions in Sequencing Technologies and Genomic Analysis Supporting Cancer Research
- Chair
-
- Motohiro Kato
- （Department of Prdiatrics, The University of Tokyo Hospital）
- Speaker
Genetic analysis of hematological malignancies by targeted sequencing using custom panels
- Kenichi Yoshida
- （Division of Cancer Evolution, National Cancer Center Japan）
Evolving Genomic Technologies and Their Potential
- Motohiro Kato
- （Department of Prdiatrics, The University of Tokyo Hospital）
- Sponsor
- Twist Bioscience
LS4
September 25 (Thu) 11:50-12:40 Room 6（Hotel Nikko Kanazawa 3F「Kujaku A」）
- Chair
-
- Taro Yamashita
- （Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences）
- Speaker
Molecular Mechanisms of Laminin γ2 Monomer in Liver Cancer: Pathological Relevance and Future Perspectives
- Kouki Nio
- （Innovative Clinical Research Center, Kanazawa University Hospital）
- Sponsor
- Abbott Japan LLC
LS5
September 25 (Thu) 11:50-12:40 Room 7（Hotel Nikko Kanazawa 3F「Kujaku B」）
Latest Perspective in Cancer Immunotherapy Research using Long-Read Sequencing
- Chair
-
- Kotoe Katayama
- （Laboratory of Sequence Analysis Human Genome Center Institute of Medical Science University of Tokyo）
- Speaker
Transcriptome Analysis using PacBio Long-Read Sequencing
- Miwako Kitazume, PhD
- （TOMY DIGITAL BIOLOGY CO., LTD.）
Cancer Immunotherapy Targeting Neoantigens: Discovery of New Therapeutic Targets using Long-Read Sequencing
- Kazuma Kiyotani
- （Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN).）
- Sponsor
- TOMY DIGITAL BIOLOGY CO., LTD.
LS6
September 25 (Thu) 11:50-12:40 Room 8（Hotel Nikko Kanazawa 3F「Kujaku C」）
Multidimensional Analysis of Tumor Immunity Using Full-Spectrum Flow Cytometry
- Chair
-
- Edmond Chua
- （Cytek Biosciences）
- Speaker
Diving Deep: Profiling Exhausted T Cells in the Tumor Microenvironment Using Full Spectrum Flow Cytometry
- Samantha Ho
- （Merck Sharp & Dohme (MSD), Singapore）
- Sponsor
- Cytek Japan Corporation
LS7
September 25 (Thu) 11:50-12:40 Room 9（Hotel Nikko Kanazawa 3F「Lumiere」）
- Chair
-
- Yasuhiko Nishioka
- （Professor and Chairman, Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University）
- Speaker
Role of Macrophages and Correlation with PD-L1 in Cancer Immunity
- Yoshihiro Komohara
- （Professor, Department of Cell Pathology, Graduate School of Medical Science, Kumamoto University）
LS8
September 25 (Thu) 11:50-12:40 Room 11（ANA Crowne Plaza Kanazawa 3F「Ootori - West」）
- Chair
-
- Shigeki Nanjo
- （Department of Respiratory Medicine, Kanazawa University Hospital）
- Speaker
Is Molecular-Targeted Therapy Necessary for Unresectable Stage III NSCLC? — Clinical Considerations from the LAURA Regimen
- Akito Hata
- （Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center）
- Sponsor
- AstraZeneca K.K.
LS9
September 25 (Thu) 11:50-12:40 Room 12（ANA Crowne Plaza Kanazawa 3F「Ootori - Central」）
LS10
September 25 (Thu) 11:50-12:40 Room 13（ANA Crowne Plaza Kanazawa 3F「Ootori - East」）
The forefront of new drug discovery: Drug discovery innovation through collaboration between doctors and companies
- Chair
-
- Takashi Seto
- （NHO Kyushu Cancer Center Thoracic Oncology）
- Speaker
Potential for Drug Development through Investigator initiated Clinical Trials
- Including Experience with Lenvatinib –- Noboru Yamamoto
- （National Cancer Center Hospital, Deputy director, Department of Experimental Therapeutics）
The future of biliary tract cancer treatment based on cancer genomic medicine
-The discovery of FGFR2 fusion genes in Japan and the path to the launch of tasurgratinib-- Tatsuhiro Shibata
- （Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.）
- Sponsor
- Eisai co., Ltd.
LS11
September 25 (Thu) 11:50-12:40 Room 14（ANA Crowne Plaza Kanazawa 3F「Zuiun 1」）
Innovation in 3D Immune Analysis
- Chair
-
- Shintaro Tanaka
- （Leica Microsystems K.K.）
- Speaker
-
- Hiroko OSHIMA
- （Cancer Research Institute, Kanazawa University）
Proposal of SpectraPlex, a Novel Technology of 3D Multiplex Imaging and AIVIA, an AI-Powered Image Analysis Software, for Cancer Immuno-Microenvironment Research
- Toshiyuki Hatano
- （Leica Microsystems K.K.）
- Sponsor
- Leica Microsystems K.K.
LS12
September 25 (Thu) 11:50-12:40 Room 15（ANA Crowne Plaza Kanazawa 3F「Zuiun 2」）
Unlock Transformative Cancer Insights: The power of multi-omics Oxford Nanopore sequencing.
- Chair
-
- Ken Osaki
- （Oxford Nanopore Technologies）
- Speaker
A compendium of human RNA structures and modifications
- Yasuhiro Murakawa
- （Kyoto University）
Expanding the potential of multi-omics analysis: The latest advancements in Oxford Nanopore sequencing
- Rie Yamashige
- （Oxford Nanopore Technologies）
- Sponsor
- Oxford Nanopore Technologies
LS13
September 26 (Fri) 11:50-12:40 Room 1（Ishikawa Ongakudo 2F「 Concert Hall」）
Innovative technologies or resources to support translational research in the field of drug development against cancer
- Chair
-
- Miyazono, Kohei
- （The University of Tokyo, Graduate School of Medicine, Applied Pathology）
- Speaker
Advanced Technical Support by BINDS: New Initiatives to Accelerate Drug Discovery in Academia
- Inoue, Tsuyoshi
- （Professor, Osaka University, Graduate School of Pharmaceutical Sciences）
An approach to preclinical R&D from seed identification to POC establishment for antitumor efficacy in academia (Drug discovery initiatives in P-PROMOTE)
- Noda, Tetsuo
- （Advisor, Director Emeritus, Japanese Foundation for Cancer Research）
- Sponsor
- Project for Promotion of Cancer Research and Therapeutic Evolution (P-PROMOTE): Team for advanced technical support and efficient research management in P-PROMOTE, The Cancer Institute of JFCR/Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS): BINDS Activity Support Team for Collaboration Promotion Office
LS14
September 26 (Fri) 11:50-12:40 Room 3（Hotel Nikko Kanazawa 4F「Tsuru A」）
- Chair
-
- Koichi Akashi
- （KYUSHU UNIVERSITY Senior Vice President: Kyushu University Director: Realization Hub for Biomedical Innovation）
- Speaker
Monitoring and pathological elucidation of lymphoma using liquid biopsy
- Takeshi Sugio
- （Division of Oncology, Stanford Medicine）
- Sponsor
- CHUGAI PHARMACEUTICAL CO.,LTD.
LS15
September 26 (Fri) 11:50-12:40 Room 4（Hotel Nikko Kanazawa 4F「Tsuru B」）
LS16
September 26 (Fri) 11:50-12:40 Room 5（Hotel Nikko Kanazawa 4F「Tsuru C」）
Future perspective of next-generation CAR-T cell therapy and automated cell manufacturing technologies
- Speaker
-
- Koji Tamada
- （Yamaguchi University Graduate School of medicine, Department of Immunology）
- Sponsor
- SHIBUYA CORPORATION
LS17
September 26 (Fri) 11:50-12:40 Room 6（Hotel Nikko Kanazawa 3F「Kujaku A」）
- Chair
-
- Kazuhito Yamamoto
- （Aichi Cancer Center）
- Speaker
Current treatments for lymphoid neoplasms : The impact of Pirtobrutinib on treatment strategies
- Jun Takizawa
- （Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine）
- Sponsor
- Nippon Shinyaku Co., Ltd.
LS18
September 26 (Fri) 11:50-12:40 Room 7（Hotel Nikko Kanazawa 3F「Kujaku B」）
Technology Development for the expanding spatial analysis of cancers
- Chair
-
- Akiyuki Satou
- （TAKARA BIO, Inc. Genome Analysis Center）
- Speaker
-
- Yutaka Suzuki
- （Life Science Data Research Center, Graduate School of Frontier Sciences, The University of Tokyo）
- Sponsor
- TAKARA BIO, Inc.
LS19
September 26 (Fri) 11:50-12:40 Room 8（Hotel Nikko Kanazawa 3F「Kujaku C」）
- Chair
-
- Seiji Yano
- （Department of Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University）
- Speaker
The Role of Gut Microbiota in the Era of Immune Checkpoint Inhibitor–Chemotherapy Combination Therapy: Implications for Febrile Neutropenia Management with G-CSF
- Kiyoshi Yoshimura
- （Department of Clinical Immuno Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa Medical University / Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine）
- Sponsor
- Kyowa Kirin Co., Ltd.
LS20
September 26 (Fri) 11:50-12:40 Room 9（Hotel Nikko Kanazawa 3F「Lumiere」）
- Speaker
Spatial analysis reveals origin of cancer
- Yosuke Tanaka
- （National Cancer Center Research Institute Division of Cellular Signaling）
- Sponsor
- 10x Genomics
LS21
September 26 (Fri) 11:50-12:40 Room 12（ANA Crowne Plaza Kanazawa 3F「Ootori - Central」）
- Chair
-
- Toshihiro Miyamoto
- （Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University.）
- Speaker
BTK inhibition in the treatment of CLL: past and future
- Yohikane Kikushige
- （Center for Cellular and Molecular Medicine, Kyushu University Hospital）
- Sponsor
- AstraZeneca K.K.
LS22
September 26 (Fri) 11:50-12:40 Room 13（ANA Crowne Plaza Kanazawa 3F「Ootori - East」）
- Chair
-
- Kato Motohiro
- （Professor, Department of Pediatrics, the University of Tokyo）
- Speaker
Treatment strategies for AML in the era of molecular targeted therapy
- Ishikawa Yuichi
- （Lecture, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine）
- Sponsor
- Astellas Pharma Inc
LS23
September 26 (Fri) 11:50-12:40 Room 14（ANA Crowne Plaza Kanazawa 3F「Zuiun 1」）
- Chair
-
- Takushi Yamamoto
- （Shimadzu Corporation, Analytical and Measuring Instruments Division, Solutions COE, Healthcare Solutions Unit.）
- Speaker
Visualization of Drug Distribution in cancer tissue by Mass Spectrometry Imaging"
— Exploring the Future of Cancer Research in Comparison with Raman Spectroscopic Analysis and Comprehensive Genetic Analysis —- Yasuto Naoi
- （Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Division of Endocrine and Breast Surgery）
- Sponsor
- Shimadzu Corporation
LS24
September 26 (Fri) 11:50-12:40 Room 15（ANA Crowne Plaza Kanazawa 3F「Zuiun 2」）
Perspectives for Adoptive Cellular Immunotherapy of Cancer -TIL, TCR-T, CAR-T-
- Chair
-
- Hiroaki Ikeda
- （Professor, Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences）
- Speaker
-
- Yutaka Kawakami
- （Professor,Department of Immunology,Graduate School of Medicine International University of Health and Welfare(IUHW)）
- Sponsor
- TOHO Holdings Co., Ltd.／REPROCELL Inc.
LS25
September 27 (Sat) 11:50-12:40 Room 4（Hotel Nikko Kanazawa 4F「Tsuru B」）
- Chair
-
- Takahiro Maeda
- （Division of Precision Medicine, Graduate School of Medical Sciences, Kyushu University）
- Speaker
Mechanisms of T Cell Activation and Inhibition in the Tumor Microenvironment (Tentative)
- Hiroyoshi Nishikawa
- （Department of Immunology, Nagoya University Graduate School of Medicine Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center Division of Cancer Immune Multicellular System Regulation, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine）
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. - Medical Affairs
LS26
September 27 (Sat) 11:50-12:40 Room 6（Hotel Nikko Kanazawa 3F「Kujaku A」）
- Chair
-
- Seiji Yano
- （Kanazawa University）
- Speaker
Mastering Bispecific Antibody
～A New Standard of Care for EGFR-Mutant NSCLC～- Hidehito Horinouchi
- （National Cancer Center Hospital）
- Sponsor
- Janssen Pharmaceutical K.K
LS27
September 27 (Sat) 11:50-12:40 Room 7（Hotel Nikko Kanazawa 3F「Kujaku B」）
Real-world data of VEN+AZA therapy in Japanese patients with acute myeloid leukemia useful for clinical practice
- Chair
-
- Seishi Ogawa
- （Department of Pathology and Tumor Biology,Kyoto University）
- Speaker
-
- Hiroki Yamaguchi
- （Department of Hematology, Nippon Medical School）
- Sponsor
- AbbVie GK
LS28
September 27 (Sat) 11:50-12:40 Room 8（Hotel Nikko Kanazawa 3F「Kujaku C」）
The Forefront of Multiplex Digital PCR Analysis in Cancer Research
- Chair
-
- Masatoshi Soejima
- （Bio-Rad Laboratories K.K.）
- Speaker
Basics of droplet digital PCR
- Ayumi Miyakawa
- （Bio-Rad Laboratories K.K.）
Multiplex ddPCR analysis toward cancer genome diagnosis at a private hospital research institute
- Yusuke Ono
- （Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital）
- Sponsor
- Bio-Rad Laboratories K.K.
LS29
September 27 (Sat) 11:50-12:40 Room 9（Hotel Nikko Kanazawa 3F「Lumiere」）
Cancer Genomic Medicine
- Chair
-
- Katsutoshi Oda
- （Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo）
- Speaker
-
- Kousuke Watanabe
- （Next-Generation Precision Medicine Development Laboratory, Graduate School of Medicine, The University of Tokyo）
- Sponsor
- KONICA MINOLTA REALM, INC.
LS30
September 27 (Sat) 11:50-12:40 Room 11（ANA Crowne Plaza Kanazawa 3F「Ootori - West」）
- Chair
-
- Motoko Yamaguchi
- Speaker
-
- Mamiko Sakata
- Sponsor
- DAIICHI SANKYO COMPANY, LIMITED
LS31
September 27 (Sat) 11:50-12:40 Room 12（ANA Crowne Plaza Kanazawa 3F「Ootori - Central」）
LS32
September 27 (Sat) 11:50-12:40 Room 13（ANA Crowne Plaza Kanazawa 3F「Ootori - East」）
Multiple Myeloma
- Chair
-
- Hideto Tamura
- （Dokkyo Medical University Saitama Medical Center Department of Diabetes, Endocrinology and Hematology）
- Speaker
Fundamentals and Potential of Antibody-Drug Conjugates (ADCs) Learned through Belantamab mafodotin
- Yusuke Furukawa
- （Teikyo University of Science Medical Education Center）
- Sponsor
- GlaxoSmithKline.K.K.
LS33
September 27 (Sat) 11:50-12:40 Room 14（ANA Crowne Plaza Kanazawa 3F「Zuiun 1」）
- Chair
-
- Makoto Iida
- （Department of Drug Discovery & Contract Service, Cosmo Bio Co., Ltd.）
- Speaker
Advancing Single-Cell Multi-Omics Analysis with Intracellular CITE-seq
- Saki Imura
- （Proteintech Japan, Co., Ltd.）
Genotype-integrated single-cell transcriptomics reveals the pathogenesis of myeloid neoplasms
- Hirotaka Matsui
- （Department of Laboratory Medicine, National Cancer Center Hospital）
- Sponsor
- Cosmo Bio Co., Ltd.／Proteintech Japan, Co., Ltd.
LS34
September 27 (Sat) 11:50-12:40 Room 15（ANA Crowne Plaza Kanazawa 3F「Zuiun 2」）
Translational Research contributing to cancer research by using PDX models
- Chair
-
- Kosei Hasegawa
- （Department of Gynecologic Oncology, Saitama Medical University International Medical Center）
- Speaker
PDX Models as a Platform for Drug Development and Translational Research
- Akinobu Hamada
- （Division of Molecular Pharmacology, National Cancer Center Research Institute）
- Sponsor
- Mediford Corporation